RNA silencing

Content sourced from Wikipedia, licensed under CC BY-SA 3.0.

RNA silencing, also known as RNA interference (RNAi), is how cells turn down or shut off genes using small non-coding RNA molecules. The best-known type uses microRNAs (miRNAs) or small interfering RNAs (siRNAs) to destroy or block messenger RNA (mRNA) so it can’t make a protein. A broader family also includes piwi-interacting RNAs (piRNAs). These small RNAs are about 20–30 nucleotides long and guide complexes to target sequences to inactivate them.

How it works in simple terms:
- A double-stranded RNA or a hairpin RNA is cut into small guide pieces (siRNA or miRNA).
- These guides join with protein complexes (like RISC) and search for matching mRNA in the cell.
- If there is a close match, the mRNA is chopped up or its translation into protein is blocked.
- Some RNA silencing pathways can also act at the level of DNA, changing chromatin to reduce or stop transcription.

Why RNA silencing matters:
- It helps defend plants and animals against viruses and transposons (genes that can move around the genome).
- It helps regulate development and cell fate, and may influence many other processes such as neuron function and metabolism.
- miRNAs, in particular, can control hundreds of target mRNAs, often producing modest decreases in protein levels but affecting many genes at once. Abnormal RNA silencing has been linked to cancers and some brain disorders.

Key players:
- siRNA: usually comes from longer double-stranded RNA and works in both the nucleus and cytoplasm to silence genes.
- miRNA: comes from hairpin precursors and mostly acts in the cytoplasm to repress translation or degrade mRNA.
- piRNA: larger, acts in animals and can affect both mRNA and DNA/chromatin; its exact biology is still being studied.
- 3' untranslated regions (3'UTRs) of mRNAs often contain miRNA binding sites (MREs) that help control gene expression.

Applications and future:
- Researchers use synthetic siRNAs or engineered short hairpin RNAs to silence specific genes in cells and animals, helping study gene function.
- There is strong interest in therapies based on RNA silencing for diseases like viral infections, cancer, eye diseases, and neurodegenerative disorders.
- Delivery of the RNA molecules to the right tissues remains a major challenge, and scientists are exploring different methods to improve safety and targeting.

Ethics and safety:
- Off-target effects, immune reactions, and delivery risks are important concerns.
- Careful risk-benefit analysis is needed as RNA silencing therapies advance toward clinical use.

In short, RNA silencing is a conserved, powerful system that uses small RNAs to regulate or shut down gene expression, with wide implications for biology, medicine, and biotechnology.